绥美凯的最新价格

Inbec is indicated for the treatment of adults and adolescents aged 12 years and older (who weigh at least 40 kg) infected with human immunodeficiency virus (HIV). HIV-infected patients, regardless of race, should be screened for the HLA-B5701 allele before starting treatment with abacavir-containing products. If the patient is known to carry the HLA-B5701 allele, he should not take products containing abacavir.

Trimax Inbec is currently the only three-in-one compound drug containing dolutegravir (DTG). One tablet contains three antiviral drugs. Treatment drugs for different stages of viral infection are integrated in the same tablet. One tablet is a complete treatment plan. One tablet per day can achieve the effect of cocktail therapy without food restrictions.

For adults and adolescents (weighing at least 40kg), the recommended dose of Sumax Inbec is one tablet, once daily.

  Adults or adolescents whose body weight is less than 40 kg should not be given Trimax Inbec because Trimax Inbec is a fixed-dose tablet and the dose cannot be reduced. Trimax Inbec is a fixed-dose tablet and should not be used in patients who require dose adjustments. If one of the active ingredients needs to be discontinued or dose adjustments made, separate formulations of dolutegravir, abacavir or lamivudine may be used. In these circumstances, physicians should refer to the respective product information for these medicines.

The original drug of Suimeike Inbec is relatively expensive, which is a big burden for patients who need to take the drug for a long time for treatment. Therefore, many patients choose the Indian version of Suimeike. Due to patent protection restrictions, many drugs are prohibited from being copied in most countries around the world. However, due to the protection of India's special patent laws, Indian Emcure Pharmaceuticals can produce drugs that are almost as effective as the original drugs and have high cost performance.

The latest price of Emcure Pharmaceutical Company in India: The specification of Suimeike produced by Emcure Pharmaceutical Company in India is 30 tablets per box, and the price is around $900. Due to the floating exchange rate, the price is not fixed. If patients want to know the specific price information of Suimeike, they can consult the medical companion travel service.